- Evotec and Bayer announce new kidney disease study
- Actithera appoints Darshan Dalal as Chief Medical Officer
- Pace appoints Ken Beyer as CEO
- EpilepsyGTx raises $33m for focal refractory epilepsy gene therapy
- Breast Cancer Now study to explore personalised drug doses
- insitro appoints Stephen Hitchcock and Vijay Pande as scientific advisors
- STADA appoints Ole Wendler Pedersen as Executive VP Legal and General Counsel
- UCB presents positive results for fenfluramine in CDKL5 deficiency disorder
- Teva announces positive results from trial of AJOVY for migraine
- Vetter announces leadership transition as Thomas Otto retires
- Samsung Bioepis announces launch of two new denosumab biosimilars in Europe
- Medicus Pharma appoints Carolyn Bonner as CFO
- Sandoz launches two new bone disease biosimilars in Europe
- Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer
- Medicus Pharma shares updates on basal cell carcinoma trials